P2-298: The novel strategy for generation of effective and safe Alzheimer's disease vaccine based on conventional influenza virus vaccine modified to express A1-11
Ghochikyan, A.; Martinez, L.; Movsesyan, N.; Mkrtichyan, M.; Petrushina, I.; Davtyan, H.; Cribbs, D.H.; Garcı́a-Sastre, A.; Agadjanyan, M.G.
Alzheimer's and Dementia 4(4): T459-T460
2008
DOI: 10.1016/j.jalz.2008.05.1374
Accession: 066981942
PDF emailed within 0-6 h: $19.90
Related References
De Bruijn, I.A.; Nauta, J.; Gerez, L.; Palache, A.M. 2004: Virosomal influenza vaccine: a safe and effective influenza vaccine with high efficacy in elderly and subjects with low pre-vaccination antibody titers Virus Research 103(1-2): 139-145Liu, Y.; Fu, C.; Ye, S.; Liang, Y.; Qi, Z.; Yao, C.; Wang, Z.; Wang, J.; Cai, S.; Tang, S.; Chen, Y.; Li, S. 2021: The inactivated vaccine of reassortant H3N2 canine influenza virus based on internal gene cassette from PR8 is safe and effective Veterinary Microbiology 254: 108997
Kanaoka, T.; Matsuoka, K.; Shaker, M. 2018: Safe and effective intradermal influenza vaccine desensitization for delayed influenza vaccine allergy Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 120(6): 666-667
Koenig, P.; Hoffmann, B.; Depner, K.R.; Reimann, I.; Teifke, J.P.; Beer, M. 2007: Detection of classical swine fever vaccine virus in blood and tissue samples of pigs vaccinated either with a conventional C-strain vaccine or a modified live marker vaccine Veterinary Microbiology 120(3-4): 343-351
Collins, J.M.; Donahue, R.N.; Tsai, Y.-T.; Manu, M.; Palena, C.; Gatti-Mays, M.E.; Marté, J.L.; Madan, R.A.; Karzai, F.; Heery, C.R.; Strauss, J.; Abdul-Sater, H.; Cordes, L.; Schlom, J.; Gulley, J.L.; Bilusic, M. 2020: Phase i Trial of a Modified Vaccinia Ankara Priming Vaccine Followed by a Fowlpox Virus Boosting Vaccine Modified to Express Brachyury and Costimulatory Molecules in Advanced Solid Tumors Oncologist 25(7): 560-E1006
Römer-Oberdörfer, A.; Veits, J.; Helferich, D.; Mettenleiter, T.C. 2008: Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus Vaccine 26(19): 2307-2313
Ge, J.; Tian, G.; Zeng, X.; Jiang, Y.; Chen, H.; Bua, Z. 2010: Generation and evaluation of a Newcastle disease virus-based H9 avian influenza live vaccine Avian Diseases 54(1 Suppl): 294-296
Lemere, C.A. 2009: Developing novel immunogens for a safe and effective Alzheimer's disease vaccine Progress in Brain Research 175: 83-93
Maier, M.; Seabrook, T.J.; Lemere, C.A. 2005: Developing novel immunogens for an effective, safe Alzheimer's disease vaccine Neuro-Degenerative Diseases 2(5): 267-272
Leong, K.H.; Ramsay, A.J.; Boyle, D.B.; Ramshaw, I.A. 1993: Expression of cytokines by recombinant fowlpox virus in mice A safe and effective vaccine strategy Journal of Leukocyte Biology 1993(Suppl ): 42
De Vleeschauwer, A.; Qiu, Y.; Van Reeth, K. 2015: Vaccination-challenge studies with a Port Chalmers/73 (H3N2)-based swine influenza virus vaccine: Reflections on vaccine strain updates and on the vaccine potency test Vaccine 33(20): 2360-2366
Song, H.; Nieto, G.R.; Perez, D.R. 2007: A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates Journal of Virology 81(17): 9238-9248
Kolibab, K.; Yang, A.; Derrick, S.C.; Waldmann, T.A.; Perera, L.P.; Morris, S.L. 2010: Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant Clinical and Vaccine Immunology: Cvi 17(5): 793-801
Shalash, A.O.; Hussein, W.M.; Skwarczynski, M.; Toth, I. 2021: Key Considerations for the Development of Safe and Effective SARS-CoV-2 Subunit Vaccine: a Peptide-Based Vaccine Alternative Advanced Science 8(16): E2100985
Kreijtz, J.H.C.M.; Wiersma, L.C.M.; De Gruyter, H.L.M.; Vogelzang-van Trierum, S.E.; van Amerongen, G.; Stittelaar, K.J.; Fouchier, R.A.M.; Osterhaus, A.D.M.E.; Sutter, G.; Rimmelzwaan, G.F. 2015: A single immunization with modified vaccinia virus Ankara-based influenza virus H7 vaccine affords protection in the influenza A(H7N9) pneumonia ferret model Journal of Infectious Diseases 211(5): 791-800
Kim, S.M.; Kim, Y.-I.; Park, S.-J.; Kim, E.-H.; Kwon, H.-I.; Si, Y.-J.; Lee, I.-W.; Song, M.-S.; Choi, Y.K. 2017: Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and its Suitability for the Marker Vaccine Strategy Journal of Virology 91(6)
Li, J.; Arévalo, M.T.; Diaz-Arévalo, D.; Chen, Y.; Choi, J.-G.; Zeng, M. 2015: Generation of a safe and effective live viral vaccine by virus self-attenuation using species-specific artificial microRNA Journal of Controlled Release: Official Journal of the Controlled Release Society 207: 70-76
Seo, Y.Bin.; Lee, J.; Song, J.Young.; Choi, H.Jung.; Cheong, H.Jin.; Kim, W.Joo. 2016: Safety and immunogenicity of influenza vaccine among HIV-infected adults: Conventional vaccine vs. intradermal vaccine Human Vaccines and Immunotherapeutics 12(2): 478-484
Divino, V.; Krishnarajah, G.; Pelton, S.I.; Mould-Quevedo, J.; Anupindi, V.R.; DeKoven, M.; Postma, M.J. 2020: A real-world study evaluating the relative vaccine effectiveness of a cell-based quadrivalent influenza vaccine compared to egg-based quadrivalent influenza vaccine in the US during the 2017-18 influenza season Vaccine 38(40): 6334-6343
Liang, X.; Sun, L.; Yu, T.; Pan, Y.; Wang, D.; Hu, X.; Fu, Z.; He, Q.; Cao, G. 2016: A CRISPR/Cas9 and Cre/Lox system-based express vaccine development strategy against re-emerging Pseudorabies virus Scientific Reports 6: 19176